Shanghai Kinetic Medical Co
Shanghai Kinetic Medical Co., Ltd, together with its subsidiaries, engages in the research, development, manufacturing, and sale of medical devices in China and internationally. The company offers invasive spinal, invasive vertebroplasty, radiofrequency ablation, orthopedic trauma implant equipment, artificial organs, orthopedic surgical instruments, and other medical products, as well as surgica… Read more
Market Cap & Net Worth: Shanghai Kinetic Medical Co (300326)
Shanghai Kinetic Medical Co (SHE:300326) has a market capitalization of $605.88 Million (CN¥4.45 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #10604 globally and #2387 in its home market, demonstrating a 0.32% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai Kinetic Medical Co's stock price CN¥6.20 by its total outstanding shares 717012682 (717.01 Million).
Shanghai Kinetic Medical Co Market Cap History: 2015 to 2026
Shanghai Kinetic Medical Co's market capitalization history from 2015 to 2026. Data shows change from $1.14 Billion to $596.11 Million (-5.86% CAGR).
Shanghai Kinetic Medical Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanghai Kinetic Medical Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.65x
Shanghai Kinetic Medical Co's market cap is 0.65 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.14 Billion | $462.89 Million | $120.65 Million | 2.45x | 9.42x |
| 2016 | $1.04 Billion | $550.60 Million | $158.84 Million | 1.89x | 6.57x |
| 2017 | $786.46 Million | $802.27 Million | $194.98 Million | 0.98x | 4.03x |
| 2018 | $802.10 Million | $930.91 Million | $462.57 Million | 0.86x | 1.73x |
| 2019 | $1.29 Billion | $1.22 Billion | $302.33 Million | 1.05x | 4.26x |
| 2020 | $1.51 Billion | $1.06 Billion | -$126.54 Million | 1.42x | N/A |
| 2021 | $1.02 Billion | $1.27 Billion | $161.78 Million | 0.80x | 6.30x |
| 2022 | $692.49 Million | $1.17 Billion | -$21.28 Million | 0.59x | N/A |
| 2023 | $608.82 Million | $956.26 Million | $112.54 Million | 0.64x | 5.41x |
| 2024 | $635.20 Million | $984.52 Million | -$105.57 Million | 0.65x | N/A |
Competitor Companies of 300326 by Market Capitalization
Companies near Shanghai Kinetic Medical Co in the global market cap rankings as of March 18, 2026.
Key companies related to Shanghai Kinetic Medical Co by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
Shanghai Kinetic Medical Co Historical Marketcap From 2015 to 2026
Between 2015 and today, Shanghai Kinetic Medical Co's market cap moved from $1.14 Billion to $ 596.11 Million, with a yearly change of -5.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥596.11 Million | +7.39% |
| 2025 | CN¥555.06 Million | -12.62% |
| 2024 | CN¥635.20 Million | +4.33% |
| 2023 | CN¥608.82 Million | -12.08% |
| 2022 | CN¥692.49 Million | -32.04% |
| 2021 | CN¥1.02 Billion | -32.49% |
| 2020 | CN¥1.51 Billion | +17.17% |
| 2019 | CN¥1.29 Billion | +60.61% |
| 2018 | CN¥802.10 Million | +1.99% |
| 2017 | CN¥786.46 Million | -24.61% |
| 2016 | CN¥1.04 Billion | -8.18% |
| 2015 | CN¥1.14 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Shanghai Kinetic Medical Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $605.88 Million USD |
| MoneyControl | $605.88 Million USD |
| MarketWatch | $605.88 Million USD |
| marketcap.company | $605.88 Million USD |
| Reuters | $605.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.